ELIZABETH YATES: Open Payments
NPI 1033809843 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 85 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $235 · 2025 $1,658
Food & beverage: $1,588Education: $70
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $340 |
| AstraZeneca Pharmaceuticals LP | 10 | $168 |
| Novo Nordisk Inc | 11 | $163 |
| Astellas Pharma US Inc | 3 | $129 |
| PFIZER INC. | 6 | $108 |
| Lilly USA, LLC | 4 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Dexcom, Inc. | 3 | $75 |
| Exact Sciences Corporation | 4 | $72 |
Products named: UBRELVY, QULIPTA, VRAYLAR, NURTEC ODT, XIFAXAN, CAPLYTA, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit.
Industry payments across NC — which companies pay providers there.
